News about Digitalization

Graph Therapeutics Taps Parse GigaLab to Accelerate AI-First Immunology Drug Discovery

Parse Biosciences and Graph Therapeutics have entered into a strategic partnership to build one of the largest and most comprehensive immune cell perturbation atlases to date.

Digitalization | 22/01/2026 | By Darshana |  209

HistoIndex Partners Houston Research Institute to Expand AI-Driven Diagnostics for MASH Care

HistoIndex has partnered with Houston Research Institute to deploy AI-powered digital pathology and fibrosis assessment tools across HRI centres, enhancing diagnostic precision and clinical decision-making for MASH patients.

Digitalization | 21/01/2026 | By News Bureau |  265

PharmaCloud Bridges Innovation and Compliance in Pharma Manufacturing Operations

Pharma manufacturing continues to grapple with a long-standing challenge: balancing innovation with strict regulatory compliance. While AI-driven technologies have the potential to significantly enhance operator capability and execution consistency, their adoption on the shop floor is often constrained by regulatory and validation requirements.

Digitalization | 20/01/2026 | By Darshana |  236

Viz.ai Launches Real-Time Clinical Intelligence Service for Salesforce Agentforce Life Sciences

The new service integrates Viz.ai’s real-time clinical data from nearly 2,000 hospitals to power intelligent, closed-loop agentic workflows for life sciences organisations.

Digitalization | 16/01/2026 | By News Bureau |  353

Illumina Launches Billion Cell Atlas to Power AI-Driven Drug Discovery

Illumina, Inc. has launched the Illumina Billion Cell Atlas, the world’s largest genome-wide genetic perturbation dataset, designed to accelerate AI-enabled drug discovery across the pharmaceutical industry.

Digitalization | 15/01/2026 | By Darshana |  273

US and European Regulators Set Principles for Responsible AI Use in Drug Development

US and European medicines regulators have jointly issued a set of guiding principles to support the safe, effective and responsible use of artificial intelligence (AI) in drug development, marking a significant step toward regulatory alignment on emerging technologies.

Digitalization | 15/01/2026 | By Darshana |  243

TetraScience, Thermo Fisher Collaborate to Accelerate AI in Biopharma R&D and Manufacturing

The partnership between TetraScience and Thermo Fisher aims to transform fragmented scientific data into AI-native workflows, enabling faster, scalable and more efficient drug development and manufacturing.

Digitalization | 13/01/2026 | By News Bureau |  338

Experts Highlight Need for AI-Based Quality and Traceability in Medicinal Plants

Experts at a national seminar hosted by IIT Delhi emphasised the need for AI-enabled farm-gate quality assessment and traceability to strengthen India’s medicinal plant supply chain, outlining a digital roadmap to enhance the global competitiveness of AYUSH raw materials.

Digitalization | 13/01/2026 | By News Bureau |  186

Sophia Genetics, MD Anderson Partner to Advance AI-Driven Precision Oncology

The strategic collaboration will combine SOPHiA GENETICS’ AI-powered analytics with MD Anderson Cancer Centre’s clinical expertise to develop next-generation sequencing tools and accelerate data-driven cancer diagnosis and treatment.

Digitalization | 12/01/2026 | By News Bureau |  173

PharmaForceIQ Strengthens AI Capabilities with Aktana Acquisition

PharmaForceIQ, an end-to-end, real-time customer engagement platform for the pharmaceutical industry, has announced the acquisition of Aktana, integrating its digital commercialization platform with Aktana’s artificial intelligence-driven field next-best-action (NBA) technology.

Digitalization | 11/01/2026 | By Darshana |  528